1.62
price up icon9.46%   0.14
after-market Handel nachbörslich: 1.64 0.02 +1.23%
loading

Finanzdaten der Oncternal Therapeutics Inc-Aktie (ONCT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
91.58%
0.569
0.297 0.179 0.106 0.203
Operating Expenses
5.89%
9.348
9.933 10.57 9.651 12.35
Benefits Costs and Expenses
5.33%
8.957
9.461 - - 11.69
Costs And Expenses
5.33%
8.957
9.461 10.57 9.651 11.69
Operating Income/Loss
8.89%
-8.779
-9.636 -10.39 -9.545 -12.14
Income/Loss From Continuing Operations Before Tax
8.47%
-8.388
-9.164 0.179 0.106 -11.49
Income/Loss From Continuing Operations After Tax
8.47%
-8.388
-9.164 -9.862 -8.966 -11.49
Net Income/Loss
8.47%
-8.388
-9.164 -9.862 -8.966 -11.49
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
105.30%
2.959
-55.80 58.96 58.72 58.52
Diluted Average Shares
105.30%
2.959
-55.80 58.96 58.72 58.52
Basic Earnings Per Share
78.08%
-2.83
-12.91 -0.17 -0.15 -0.20
Diluted Earnings Per Share
78.08%
-2.83
-12.91 -0.17 -0.15 -0.20
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):